|
% Male
|
74%
|
65%
|
|
Mean Age (years)
|
43
|
41
|
|
Primary HIV risk factor (%)
|
IVDU (53%)
|
IVDU (53%)
|
|
CDC C status (%)
|
44%
|
34%
|
|
Main reasons for TDF based regimen (%)
|
Virological failure (59%)
|
Virological failure (48%)
|
| |
Toxicity management (19%)
|
Simplification (20%)
|
|
Previous time on ARV; Months. Median (IQR)
|
70 (21–111)
|
73 (34–111)
|
|
Most common acompanying NRTIs
|
3TC or FTC (36%)
|
3TC or FTC (65%)
|
| |
AZT or d4T (26%)
|
AZT or d4T (7%)
|
| |
ddI (11%)
|
ddI (13%)
|
|
Median BL HIV RNA, c/mL (log)
|
3.9
|
3.3
|
|
Mean BL CD4 count (cell/mm3)
|
335
|
387
|
